Abstract Insulin-secreting pancreatic beta cells play a key role in the pathogenesis of diabetes mellitus. Potential new treatments for this disease include cell-replacement therapies using embryonic stem cells (ESCs). We have generated ESCs from a transgenic mouse model, mouse insulin 1 promoter (MIP) green fluorescent protein (GFP) mice, in which embryonic and adult beta cells are genetically tagged with GFP. The aim of the present study is to examine the differentiation potential of MIP-GFP ESCs in the microenvironment of the kidney capsule. The ESCs grew rapidly and formed a teratoma with GFP-expressing beta-like cells present in clusters that formed a cord-like structure similar to what is seen in the embryonic pancreas. These structures also included glucagon-expressing alpha cells and amylaseexpressing acinar cells. Electron microscopic analysis showed insulin-like granules in columnar epithelium with microvilli adjacent to exocrine-like granule-containing cells. The MIP-GFP ESCs should be a useful research tool to study the differentiation capacity of ESCs toward pancreatic lineages.
Embryonic stem cells (ESCs) possess the unique ability to be cultured indefinitely in an undifferentiated state and then to differentiate into cells of all three germ layers: ectoderm, mesoderm, and endoderm (Thomson et al. 1998; ItskovitzEldor et al. 2000; Reubinoff et al. 2000) . Thus, they represent a potentially unlimited source of functional insulin-secreting pancreatic beta cells that could be used as a cell-based therapy for the treatment of diabetes mellitus (Robertson 2004; Street et al. 2004) . In this regard, D 'Amour et al. (2006) have recently described a stepwise protocol to generate insulin-producing cells by in vitro culture that recapitulates many of the features of normal embryonic development. However, the cells appear to be immature, as indicated by the co-expression of insulin and glucagon and their poor secretory response to glucose. Subsequently, the same group showed that ESC-derived pancreatic endoderm could differentiate into glucoseresponsive endocrine cells after implantation into mice (Kroon et al. 2008) . These studies indicate the potential of human ESCs for generating pancreatic beta cells for therapeutic purposes. In this paper, we describe the generation and preliminary characterization of ESCs from MIP-GFP transgenic mice (Hara et al. 2003) . These mice express GFP in embryonic and adult beta cells under the control of the mouse insulin 1 promoter. The MIP-GFP ESCs may allow us to visualize beta-cell formation in real time at the single-cell level.
Mouse ESC lines were derived from E3.5 blastocysts of MIP-GFP mice on a C57BL/6 background essentially as described by Nagy et al. (2003) . We obtained three lines: MIP-GFP ESC lines 2, 4, and 9. Karyotype analysis revealed that all three lines had a normal complement of 40 chromosomes (2 and 4 were 40, XY, and 9 was 40, XX). Since line 2 grew more robustly than the others, we used it in subsequent studies. These ESCs were free of common mouse pathogens as tested by polymerase chain reaction (PCR) using the MU developed "Infectious Microbe PCR Amplification Test" (IMPACT) [MU Research Animal Diagnostic Laboratory (RADIL), Columbia, MO]. MIP-GFP ESC 2 was injected into mouse blastocysts and found to be germline competent. These cells were strongly positive (by quantitative real-time PCR-data not shown) for a number of molecular markers of undifferentiated pluripotent mouse ESCs, including octamer-binding protein 3/4 (Oct3/4; Scholer et al. 1989; Okazawa et al. 1991) , Nanog (Chambers et al. 2003; Hart et al. 2004; Wu and Yao 2005) , and Rex-1 (Hosler et al. 1989) .
The MIP-GFP ESCs were co-cultured with an inactivated feeder layer of primary mouse embryonic fibroblasts (MEFs). Prior to plating the ESCs, the MEFs were mitotically inactivated by treatment with mitomycin C. The MIP-GFP ESCs were cultured in Dulbecco's modified Eagle medium (high glucose and no pyruvate) supplemented with 15% fetal bovine serum (ESC qualified; HyClone, Logan, UT), 5% knockout serum replacement (Invitrogen, Carlsbad, CA), 2 mM L-glutamine, 1% penicillin/streptavidin (HyClone), 1× non-essential amino acids (HyClone), 0.1 mM β-mercaptoethanol, and 1,000 U/ mL leukemia inhibitory factor (LIF; Millipore, Billerica, MA).
To study beta-cell formation in tetratomas, we injected 1×10 6 MIP-GFP ESCs under the kidney capsule of syngeneic male C57BL/6 mice (n=8). The mice were monitored daily and killed after 4 wk. The grafts were excised and examined histologically. A cluster of GFPexpressing cells in the graft was microdissected including the surrounding tissue, fixed with 4% paraformaldehyde (PFA), and paraffin-embedded or frozen. The sections were stained for insulin (Dako, Carpinteria, CA), glucagon, and amylase (Sigma-Aldrich, St. Louis, MO). Microscopic images were taken with a Nikon Eclipse E800 microscope with confocal attachment (New York, NY) and an Olympus IX80 DSU spinning disk confocal microscope (Melville, NY). Three-dimensional reconstruction was carried out using a stack of images taken by a Leica SP5 AOBS spectral two-photon confocal microscope (Wetzlar, Germany). The GFP-expressing cells were mapped using an Olympus IX80 microscope and the Stereo Investigator Imaging System (MicroBrightField, Williston, VT). This procedure allowed the number of GFP-expressing cells to be precisely quantified with spatial information to a depth of~1 mm. For transmission electron microscopic (TEM) analysis, the GFP-expressing regions were fixed with 4% PFA and 0.02% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for 2 hr and embedded in resin. Pancreata from E13.5 embryos were excised from MIP-GFP mice and treated the same way. Sections (80 nm) were stained with uranyl acetate plus lead citrate for TEM observation.
The MIP-GFP ESCs transplanted under the kidney capsule grew rapidly and formed a teratoma (n = 8; Fig. 1A ) consisting of cell types originating from all three germ layers (Fig. 1B) . GFP-expressing cells were observed in clusters (Fig. 1C) branching pattern (Fig. 1D ) and cord-like structures ( Fig. 2A,B) . Three-dimensional reconstruction using a stack of images taken with a two-photon confocal microscope revealed the spatial distribution of GFP-expressing cells in the clusters ( Fig. 2C ; also see movie in Supplemental data 1). Each cluster was comprised of 35±16 cells (n=8; Fig. 2D and movie in Supplemental data 2). The number of GFP-positive clusters within each teratoma varied from 30-50 at Week 4. Immunohistochemical analysis of the clusters showed insulin staining of the GFP-expressing cells confirming the beta-cell specific expression of MIP-GFP transgene (Fig. 2E) . We also observed glucagonpositive cells adjacent to insulin-positive cells (Fig. 2F ) and amylase-positive cells (Fig. 2G,H) . Thus, the clusters and surrounding cells include cells from both endocrine and exocrine cells of the pancreas. We did not observe bihormonal cells (i.e., insulin and glucagon co-expression, data not shown).
We also examined the ultrastructure of the GFPexpressing and adjacent cells by electron microscopy (Fig. 3) . We observed epithelial cells having secretory granules with the dense core and halo similar to that of insulin-secreting pancreatic beta cells and adjacent cells with characteristic exocrine-like secretory granules and microvilli (Fig. 3A,B) . Cells containing glucagon-like secretory granules were also observed (Fig. 3C) . The insulin-like granules present in the teratomas appear to resemble immature-type secretory granules of embryonic (E13.5) beta cells (Fig. 3D) .
Here, we describe the generation and preliminary characterization of MIP-GFP ESCs. The MIP-GFP ESCs can generate beta-like cells in teratomas and, thus, may be useful for studying beta-cell formation in vitro. The MIP-GFP ESCs may have several advantages over standard ESCs for studying beta-cell formation in vitro: (1) The GFP-expressing cells can be readily identified visually and quantified; (2) the expression of GFP as a marker for beta cells circumvents the problems associated with identification of beta cells by insulin staining, which can be confounded by the absorption of external insulin from the culture media (Rajagopal et al. 2003) ; (3) proteins, which is also prone to amplification artifacts; and (4) the use of the insulin 1 promoter separates insulin expression in differentiated ESCs derived from cells of endodermal origin from those of neuronal cell lineage, as neuronal cells express only insulin II (Deltour et al. 1993; Devaskar et al. 1993; Ku et al. 2007 ). Yolk sac and fetal liver express both insulin I and II, where the latter predominates (Devaskar et al. 1993; Giddings et al. 1994) . In summary, MIP-GFP ESCs may be useful in defining culture conditions for reproducible and efficient generation of beta cells, a first step in generating beta cells for therapeutic studies.
